The data demonstrate that treatment with FimH or Msl neither inhibited nor enhanced viral infection in a dose-dependent manner, whereas as expected, GRFT inhibited both tested viruses with different potencies (Figure 1A). The gene discussed is MFN2; the disease is viral infectious disease.